Citurgia Biochemicals has accepted the resignation of Yatendra Kumar as Company Secretary and Compliance Officer, effective July 24, 2026. Kumar, who also served as a Key Managerial Personnel, tendered his resignation on July 24, 2026, to pursue career opportunities outside the organization. The change in leadership marks a transition for the compliance function, with the Board of Directors set to formally consider and accept the resignation during its upcoming meeting.

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Kashi Nath, Whole Time Director, confirming that Kumar’s services will cease at the close of business hours on July 24, 2026. The Board expressed appreciation for the valuable services rendered by Kumar during his tenure with the company.

Resignation Details

The following table outlines the key details regarding the cessation of employment:

As per regulatory requirements, the resignation letter will be placed before the Board of Directors for formal acceptance. The company has disclosed all necessary particulars under Annexure 1 of the LODR regulations, noting no relationships between directors or other appointment-related disclosures were applicable in this instance.

Citurgia Biochemicals Limited reported a widened net loss for the financial year ended March 31, 2026, as the company recorded zero income from operations for the period. The net loss for the year stood at ₹74.25 lakh, an increase from the net loss of ₹42.31 lakh reported in the previous year ended March 31, 2025. For the quarter ended March 31, 2026, the company reported a net loss of ₹25.82 lakh, compared to a net loss of ₹11.93 lakh in the corresponding quarter of the previous year.

The company's equity share capital remained constant at ₹2,641.91 lakh across the reported periods. Earnings per share (EPS) for the year ended March 31, 2026, was reported at (0.000) on both a basic and diluted basis, consistent with the EPS reported for the financial year 2025. The financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on May 30, 2026.

Financial Performance Summary

The following table outlines the key financial figures for Citurgia Biochemicals Limited for the quarter and year ended March 31, 2026, and the corresponding periods in the previous year:

Regulatory Disclosures

The audited financial results are an extract of the detailed format filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditor of the company has carried out the audit report of the financial results. The complete format of the quarterly financial results is available on the websites of the stock exchanges and the company's official website.